Annual CFO
-$21.66 M
+$6.58 M+23.30%
31 December 2023
Summary:
Cytosorbents annual cash flow from operations is currently -$21.66 million, with the most recent change of +$6.58 million (+23.30%) on 31 December 2023. During the last 3 years, it has fallen by -$16.04 million (-285.78%). CTSO annual CFO is now -815.53% below its all-time high of -$2.37 million, reached on 31 December 2008.CTSO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$2.46 M
+$2.33 M+48.67%
30 September 2024
Summary:
Cytosorbents quarterly cash flow from operations is currently -$2.46 million, with the most recent change of +$2.33 million (+48.67%) on 30 September 2024. Over the past year, it has increased by +$2.75 million (+52.73%). CTSO quarterly CFO is now -226.98% below its all-time high of $1.94 million, reached on 30 June 2020.CTSO Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$18.49 M
+$2.75 M+12.92%
30 September 2024
Summary:
Cytosorbents TTM cash flow from operations is currently -$18.49 million, with the most recent change of +$2.75 million (+12.92%) on 30 September 2024. Over the past year, it has increased by +$2.09 million (+10.18%). CTSO TTM CFO is now -183000.00% below its all-time high of -$10.10 thousand, reached on 30 November 2005.CTSO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTSO Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.3% | +52.7% | +10.2% |
| 3 y3 years | -285.8% | +40.5% | -93.2% |
| 5 y5 years | -99.8% | +52.7% | -20.5% |
CTSO Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -285.8% | +23.3% | at high | +69.7% | -93.2% | +34.9% |
| 5 y | 5 years | -285.8% | +23.3% | -227.0% | +69.7% | -289.5% | +34.9% |
| alltime | all time | -815.5% | +23.3% | -227.0% | +69.7% | <-9999.0% | +34.9% |
Cytosorbents Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.46 M(-48.7%) | -$18.49 M(-12.9%) |
| June 2024 | - | -$4.79 M(-0.7%) | -$21.24 M(-9.1%) |
| Mar 2024 | - | -$4.83 M(-24.6%) | -$23.38 M(+8.0%) |
| Dec 2023 | -$21.66 M(-23.3%) | -$6.41 M(+23.1%) | -$21.66 M(+5.2%) |
| Sept 2023 | - | -$5.21 M(-24.9%) | -$20.59 M(-6.9%) |
| June 2023 | - | -$6.93 M(+123.1%) | -$22.12 M(-4.8%) |
| Mar 2023 | - | -$3.11 M(-41.8%) | -$23.22 M(-17.7%) |
| Dec 2022 | -$28.23 M(+101.6%) | -$5.34 M(-20.7%) | -$28.23 M(-0.5%) |
| Sept 2022 | - | -$6.73 M(-16.2%) | -$28.39 M(+10.1%) |
| June 2022 | - | -$8.04 M(-1.0%) | -$25.78 M(+30.4%) |
| Mar 2022 | - | -$8.12 M(+47.8%) | -$19.78 M(+41.2%) |
| Dec 2021 | -$14.01 M(+149.5%) | -$5.49 M(+32.9%) | -$14.01 M(+46.3%) |
| Sept 2021 | - | -$4.13 M(+103.0%) | -$9.57 M(+9.7%) |
| June 2021 | - | -$2.04 M(-13.1%) | -$8.72 M(+83.7%) |
| Mar 2021 | - | -$2.34 M(+121.6%) | -$4.75 M(-15.4%) |
| Dec 2020 | -$5.61 M(-66.5%) | -$1.06 M(-67.8%) | -$5.61 M(-35.3%) |
| Sept 2020 | - | -$3.28 M(-269.5%) | -$8.68 M(-18.1%) |
| June 2020 | - | $1.94 M(-160.4%) | -$10.60 M(-32.6%) |
| Mar 2020 | - | -$3.21 M(-22.2%) | -$15.73 M(-6.1%) |
| Dec 2019 | -$16.76 M(+54.6%) | -$4.12 M(-20.8%) | -$16.76 M(+9.2%) |
| Sept 2019 | - | -$5.21 M(+63.3%) | -$15.34 M(+20.1%) |
| June 2019 | - | -$3.19 M(-24.7%) | -$12.77 M(-0.8%) |
| Mar 2019 | - | -$4.24 M(+56.5%) | -$12.87 M(+18.8%) |
| Dec 2018 | -$10.84 M(+67.8%) | -$2.71 M(+2.7%) | -$10.84 M(+26.9%) |
| Sept 2018 | - | -$2.64 M(-20.0%) | -$8.54 M(+5.6%) |
| June 2018 | - | -$3.29 M(+49.4%) | -$8.09 M(+21.1%) |
| Mar 2018 | - | -$2.20 M(+438.2%) | -$6.68 M(+3.4%) |
| Dec 2017 | -$6.46 M(-4.0%) | -$409.50 K(-81.2%) | -$6.46 M(-9.4%) |
| Sept 2017 | - | -$2.18 M(+15.9%) | -$7.13 M(-3.8%) |
| June 2017 | - | -$1.88 M(-5.1%) | -$7.42 M(-0.5%) |
| Mar 2017 | - | -$1.98 M(+83.9%) | -$7.45 M(+10.7%) |
| Dec 2016 | -$6.73 M(-25.6%) | -$1.08 M(-56.3%) | -$6.73 M(-14.6%) |
| Sept 2016 | - | -$2.47 M(+28.4%) | -$7.88 M(+2.7%) |
| June 2016 | - | -$1.92 M(+52.4%) | -$7.67 M(-8.1%) |
| Mar 2016 | - | -$1.26 M(-43.3%) | -$8.35 M(-7.7%) |
| Dec 2015 | -$9.05 M | -$2.23 M(-1.7%) | -$9.05 M(+1.5%) |
| Sept 2015 | - | -$2.26 M(-12.9%) | -$8.91 M(+3.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2015 | - | -$2.60 M(+32.5%) | -$8.58 M(+15.3%) |
| Mar 2015 | - | -$1.96 M(-6.3%) | -$7.44 M(+18.5%) |
| Dec 2014 | -$6.28 M(+80.0%) | -$2.09 M(+8.5%) | -$6.28 M(+18.7%) |
| Sept 2014 | - | -$1.93 M(+32.0%) | -$5.29 M(+35.1%) |
| June 2014 | - | -$1.46 M(+82.6%) | -$3.92 M(+12.6%) |
| Mar 2014 | - | -$800.10 K(-27.4%) | -$3.48 M(-0.3%) |
| Dec 2013 | -$3.49 M(-3.5%) | -$1.10 M(+99.2%) | -$3.49 M(+10.8%) |
| Sept 2013 | - | -$553.60 K(-45.9%) | -$3.15 M(-2.5%) |
| June 2013 | - | -$1.02 M(+26.5%) | -$3.23 M(-3.7%) |
| Mar 2013 | - | -$809.50 K(+6.2%) | -$3.35 M(-7.3%) |
| Dec 2012 | -$3.62 M(-5.5%) | -$761.90 K(+19.8%) | -$3.62 M(-8.8%) |
| Sept 2012 | - | -$635.80 K(-44.5%) | -$3.96 M(-10.5%) |
| June 2012 | - | -$1.15 M(+6.9%) | -$4.43 M(+2.6%) |
| Mar 2012 | - | -$1.07 M(-3.3%) | -$4.31 M(+12.6%) |
| Dec 2011 | -$3.83 M(+54.5%) | -$1.11 M(+0.9%) | -$3.83 M(+13.0%) |
| Sept 2011 | - | -$1.10 M(+6.4%) | -$3.39 M(+15.9%) |
| June 2011 | - | -$1.03 M(+75.6%) | -$2.92 M(+10.6%) |
| Mar 2011 | - | -$588.00 K(-12.0%) | -$2.64 M(+6.7%) |
| Dec 2010 | -$2.48 M(-7.4%) | -$668.20 K(+5.3%) | -$2.48 M(+9.0%) |
| Sept 2010 | - | -$634.50 K(-15.7%) | -$2.27 M(-2.8%) |
| June 2010 | - | -$752.70 K(+78.4%) | -$2.34 M(+1.1%) |
| Mar 2010 | - | -$421.80 K(-8.8%) | -$2.31 M(-13.5%) |
| Dec 2009 | -$2.67 M(+13.1%) | -$462.70 K(-33.9%) | -$2.67 M(+1.5%) |
| Sept 2009 | - | -$700.30 K(-3.7%) | -$2.63 M(-11.9%) |
| June 2009 | - | -$727.50 K(-7.2%) | -$2.99 M(+3.5%) |
| Mar 2009 | - | -$784.10 K(+85.5%) | -$2.89 M(+22.2%) |
| Dec 2008 | -$2.37 M(-10.0%) | -$422.80 K(-59.9%) | -$2.37 M(-5.6%) |
| Sept 2008 | - | -$1.05 M(+68.0%) | -$2.51 M(+17.0%) |
| June 2008 | - | -$627.80 K(+141.6%) | -$2.14 M(-4.2%) |
| Mar 2008 | - | -$259.80 K(-53.9%) | -$2.24 M(-14.9%) |
| Dec 2007 | -$2.63 M(-7.8%) | -$563.00 K(-18.6%) | -$2.63 M(+27.3%) |
| Sept 2007 | - | -$691.30 K(-4.3%) | -$2.06 M(+50.3%) |
| June 2007 | - | -$722.20 K(+10.9%) | -$1.37 M(+110.9%) |
| Mar 2007 | - | -$651.30 K(>+9900.0%) | -$651.30 K(+4689.0%) |
| Dec 2006 | -$2.85 M | - | - |
| Feb 2006 | - | -$3500.00(-100.8%) | -$13.60 K(+34.7%) |
| Nov 2005 | - | $463.50 K(-197.9%) | -$10.10 K(-97.9%) |
| Aug 2005 | - | -$473.60 K | -$473.60 K |
FAQ
- What is Cytosorbents annual cash flow from operations?
- What is the all time high annual CFO for Cytosorbents?
- What is Cytosorbents annual CFO year-on-year change?
- What is Cytosorbents quarterly cash flow from operations?
- What is the all time high quarterly CFO for Cytosorbents?
- What is Cytosorbents quarterly CFO year-on-year change?
- What is Cytosorbents TTM cash flow from operations?
- What is the all time high TTM CFO for Cytosorbents?
- What is Cytosorbents TTM CFO year-on-year change?
What is Cytosorbents annual cash flow from operations?
The current annual CFO of CTSO is -$21.66 M
What is the all time high annual CFO for Cytosorbents?
Cytosorbents all-time high annual cash flow from operations is -$2.37 M
What is Cytosorbents annual CFO year-on-year change?
Over the past year, CTSO annual cash flow from operations has changed by +$6.58 M (+23.30%)
What is Cytosorbents quarterly cash flow from operations?
The current quarterly CFO of CTSO is -$2.46 M
What is the all time high quarterly CFO for Cytosorbents?
Cytosorbents all-time high quarterly cash flow from operations is $1.94 M
What is Cytosorbents quarterly CFO year-on-year change?
Over the past year, CTSO quarterly cash flow from operations has changed by +$2.75 M (+52.73%)
What is Cytosorbents TTM cash flow from operations?
The current TTM CFO of CTSO is -$18.49 M
What is the all time high TTM CFO for Cytosorbents?
Cytosorbents all-time high TTM cash flow from operations is -$10.10 K
What is Cytosorbents TTM CFO year-on-year change?
Over the past year, CTSO TTM cash flow from operations has changed by +$2.09 M (+10.18%)